Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Dolutegravir-Based Antiretroviral Therapy for Patients Co-Infected with Tuberculosis and Hiv: A Multicenter, Noncomparative, Open-Label, Randomized Trial.

Dooley KE, Kaplan R, Mwelase N, Grinsztejn B, Ticona E, Lacerda M, Sued O, Belonosova E, Ait-Khaled M, Angelis K, Brown D, Singh R, Talarico CL, Tenorio AR, Keegan MR, Aboud M; INSPIRING study group.

Clin Infect Dis. 2019 Mar 28. pii: ciz256. doi: 10.1093/cid/ciz256. [Epub ahead of print]

PMID:
30918967
2.

Evaluation of the metabolism of propranolol by linear ion trap technology in mouse, rat, dog, monkey, and human cryopreserved hepatocytes.

Baughman TM, Talarico CL, Soglia JR.

Rapid Commun Mass Spectrom. 2009 Jul;23(14):2146-50. doi: 10.1002/rcm.4130.

PMID:
19517456
3.

Interactions of 1263W94 with other antiviral agents in inhibition of human cytomegalovirus replication.

Selleseth DW, Talarico CL, Miller T, Lutz MW, Biron KK, Harvey RJ.

Antimicrob Agents Chemother. 2003 Apr;47(4):1468-71.

4.

Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV shedding.

Lalezari JP, Aberg JA, Wang LH, Wire MB, Miner R, Snowden W, Talarico CL, Shaw S, Jacobson MA, Drew WL.

Antimicrob Agents Chemother. 2002 Sep;46(9):2969-76.

5.

Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.

Biron KK, Harvey RJ, Chamberlain SC, Good SS, Smith AA 3rd, Davis MG, Talarico CL, Miller WH, Ferris R, Dornsife RE, Stanat SC, Drach JC, Townsend LB, Koszalka GW.

Antimicrob Agents Chemother. 2002 Aug;46(8):2365-72.

6.

Controlled trial of acyclovir for chickenpox evaluating time of initiation and duration of therapy and viral resistance.

Balfour HH Jr, Edelman CK, Anderson RS, Reed NV, Slivken RM, Marmor LH, Dix L, Aeppli D, Talarico CL.

Pediatr Infect Dis J. 2001 Oct;20(10):919-26.

PMID:
11642624
7.

Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate.

Oram RJ, Marcellino D, Strauss D, Gustafson E, Talarico CL, Root AK, Sharma PL, Thompson K, Fingeroth JD, Crumpacker C, Herold BC.

J Infect Dis. 2000 Apr;181(4):1458-61. Epub 2000 Apr 13.

PMID:
10762577
8.

Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein.

Talarico CL, Burnette TC, Miller WH, Smith SL, Davis MG, Stanat SC, Ng TI, He Z, Coen DM, Roizman B, Biron KK.

Antimicrob Agents Chemother. 1999 Aug;43(8):1941-6.

9.

Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.

Westphal EM, Mauser A, Swenson J, Davis MG, Talarico CL, Kenney SC.

Cancer Res. 1999 Apr 1;59(7):1485-91.

10.

Emergence of a ganciclovir-resistant human cytomegalovirus strain with a new UL97 mutation in an AIDS patient.

Baldanti F, Simoncini L, Talarico CL, Sarasini A, Biron KK, Gerna G.

AIDS. 1998 May 7;12(7):816-8. No abstract available.

PMID:
9619816
11.

The Cys607-->Tyr change in the UL97 phosphotransferase confers ganciclovir resistance to two human cytomegalovirus strains recovered from two immunocompromised patients.

Baldanti F, Underwood MR, Talarico CL, Simoncini L, Sarasini A, Biron KK, Gerna G.

Antimicrob Agents Chemother. 1998 Feb;42(2):444-6.

12.

Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir.

Hanson MN, Preheim LC, Chou S, Talarico CL, Biron KK, Erice A.

Antimicrob Agents Chemother. 1995 May;39(5):1204-5.

13.

Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance.

Chou S, Erice A, Jordan MC, Vercellotti GM, Michels KR, Talarico CL, Stanat SC, Biron KK.

J Infect Dis. 1995 Mar;171(3):576-83.

PMID:
7876604
14.

A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate.

Baldanti F, Silini E, Sarasini A, Talarico CL, Stanat SC, Biron KK, Furione M, Bono F, Pal├╣ G, Gerna G.

J Virol. 1995 Feb;69(2):796-800.

15.

Phenotypic and genotypic characterization of acyclovir-resistant varicella-zoster viruses isolated from persons with AIDS.

Boivin G, Edelman CK, Pedneault L, Talarico CL, Biron KK, Balfour HH Jr.

J Infect Dis. 1994 Jul;170(1):68-75.

PMID:
8014522
17.

A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells.

Sullivan V, Talarico CL, Stanat SC, Davis M, Coen DM, Biron KK.

Nature. 1992 Sep 3;359(6390):85. No abstract available.

PMID:
1326083
18.

A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells.

Sullivan V, Talarico CL, Stanat SC, Davis M, Coen DM, Biron KK.

Nature. 1992 Jul 9;358(6382):162-4. Erratum in: Nature 1993 Dec 23-30;366(6457):756. Nature. 1992 Sep 3;359(6390):85.

PMID:
1319560
19.

Gorlin's syndrome with associated odontogenic cysts.

Lovin JD, Talarico CL, Wegert SL, Gaynor LF, Sutley SS.

Pediatr Radiol. 1991;21(8):584-7.

PMID:
1815182

Supplemental Content

Loading ...
Support Center